Jason A Keyes insider trades

Open-market stock purchases and sales by Jason A Keyes, Chief Financial Officer at BlossomHill Therapeutics, Inc, from SEC Form 4 filings since Jul 12, 2016.

Recent trades

DateStockTradeValue
Aug 10, 2026BLSM BlossomHill Therapeutics, IncBought$11.2K
Aug 6, 2026BLSM BlossomHill Therapeutics, IncBought (not open market)—
May 21, 2026ACTU Actuate Therapeutics, IncBought (not open market)—

Companies traded

  • BLSM BlossomHill Therapeutics, Inc: 1 buy, last Aug 10, 2026
  • ACTU Actuate Therapeutics, Inc: other filings, last May 21, 2026
  • EQ Equillium, Inc: 17 sales, last Feb 14, 2025
  • SESN Sesen Bio, Inc: other filings, last Jun 22, 2022
  • OREX Orexigen Therapeutics, Inc: other filings, last Oct 13, 2017

Get free alerts when Jason A Keyes files a new trade →